TrialDiabetes, obesity & metabolism2022

Immunogenicity of LY2963016 insulin glargine and Lantus® insulin glargine in Chinese patients with type 1 or type 2 diabetes mellitus.

Weimin Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.